225 related articles for article (PubMed ID: 16317087)
1. Both hypomethylation and hypermethylation in a 0.2-kb region of a DNA repeat in cancer.
Nishiyama R; Qi L; Lacey M; Ehrlich M
Mol Cancer Res; 2005 Nov; 3(11):617-26. PubMed ID: 16317087
[TBL] [Abstract][Full Text] [Related]
2. A DNA repeat, NBL2, is hypermethylated in some cancers but hypomethylated in others.
Nishiyama R; Qi L; Tsumagari K; Weissbecker K; Dubeau L; Champagne M; Sikka S; Nagai H; Ehrlich M
Cancer Biol Ther; 2005 Apr; 4(4):440-8. PubMed ID: 15846090
[TBL] [Abstract][Full Text] [Related]
3. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
[TBL] [Abstract][Full Text] [Related]
4. Cancer-linked DNA hypomethylation and its relationship to hypermethylation.
Ehrlich M
Curr Top Microbiol Immunol; 2006; 310():251-74. PubMed ID: 16909914
[TBL] [Abstract][Full Text] [Related]
5. Hypomethylation and hypermethylation of DNA in Wilms tumors.
Ehrlich M; Jiang G; Fiala E; Dome JS; Yu MC; Long TI; Youn B; Sohn OS; Widschwendter M; Tomlinson GE; Chintagumpala M; Champagne M; Parham D; Liang G; Malik K; Laird PW
Oncogene; 2002 Sep; 21(43):6694-702. PubMed ID: 12242669
[TBL] [Abstract][Full Text] [Related]
6. Hemimethylation footprints of DNA demethylation in cancer.
Shao C; Lacey M; Dubeau L; Ehrlich M
Epigenetics; 2009 Apr; 4(3):165-75. PubMed ID: 19287214
[TBL] [Abstract][Full Text] [Related]
7. Satellite 2 methylation patterns in normal and ICF syndrome cells and association of hypomethylation with advanced replication.
Hassan KM; Norwood T; Gimelli G; Gartler SM; Hansen RS
Hum Genet; 2001 Oct; 109(4):452-62. PubMed ID: 11702227
[TBL] [Abstract][Full Text] [Related]
8. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
9. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein.
Park IY; Sohn BH; Yu E; Suh DJ; Chung YH; Lee JH; Surzycki SJ; Lee YI
Gastroenterology; 2007 Apr; 132(4):1476-94. PubMed ID: 17408664
[TBL] [Abstract][Full Text] [Related]
10. Identification of differentially methylated sites within unmethylated DNA domains in normal and cancer cells.
Tryndyak V; Kovalchuk O; Pogribny IP
Anal Biochem; 2006 Sep; 356(2):202-7. PubMed ID: 16824473
[TBL] [Abstract][Full Text] [Related]
11. Frequent inactivation of hSRBC in ovarian cancers by promoter CpG island hypermethylation.
Tong SY; Ki KD; Lee JM; Kang MJ; Ha TK; Chung SI; Chi SG; Lee SK
Acta Obstet Gynecol Scand; 2010 May; 89(5):629-35. PubMed ID: 20423276
[TBL] [Abstract][Full Text] [Related]
12. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
Kao RH; Huang LC; Hsu YH
Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
[TBL] [Abstract][Full Text] [Related]
13. Investigation of genomic methylation status using methylation-specific and bisulfite sequencing polymerase chain reaction.
Carless MA
Methods Mol Biol; 2015; 1288():193-212. PubMed ID: 25827881
[TBL] [Abstract][Full Text] [Related]
14. DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity.
Yegnasubramanian S; Haffner MC; Zhang Y; Gurel B; Cornish TC; Wu Z; Irizarry RA; Morgan J; Hicks J; DeWeese TL; Isaacs WB; Bova GS; De Marzo AM; Nelson WG
Cancer Res; 2008 Nov; 68(21):8954-67. PubMed ID: 18974140
[TBL] [Abstract][Full Text] [Related]
15. Changes in the DNA methylation profile of the rat H19 gene upstream region during development and transgenic hepatocarcinogenesis and its role in the imprinted transcriptional regulation of the H19 gene.
Manoharan H; Babcock K; Pitot HC
Mol Carcinog; 2004 Sep; 41(1):1-16. PubMed ID: 15352122
[TBL] [Abstract][Full Text] [Related]
16. General implications for CpG hot spot mutations: methylation patterns of the human iduronate-2-sulfatase gene locus.
Tomatsu S; Orii KO; Bi Y; Gutierrez MA; Nishioka T; Yamaguchi S; Kondo N; Orii T; Noguchi A; Sly WS
Hum Mutat; 2004 Jun; 23(6):590-8. PubMed ID: 15146464
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the clinical feasibility: The direct bisulfite genomic sequencing for examination of methylated status of protocadherin10 (PCDH10) promoter to predict the prognosis of gastric cancer.
Hou YC; Deng JY; Zhang RP; Xie XM; Cui JL; Wu WP; Hao XS; Liang H
Cancer Biomark; 2015; 15(5):567-73. PubMed ID: 26406945
[TBL] [Abstract][Full Text] [Related]
18. Frequent hypomethylation in multiple promoter CpG islands is associated with global hypomethylation, but not with frequent promoter hypermethylation.
Kaneda A; Tsukamoto T; Takamura-Enya T; Watanabe N; Kaminishi M; Sugimura T; Tatematsu M; Ushijima T
Cancer Sci; 2004 Jan; 95(1):58-64. PubMed ID: 14720328
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation in ovarian cancer. II. Expression of DNA methyltransferases in ovarian cancer cell lines and normal ovarian epithelial cells.
Ahluwalia A; Hurteau JA; Bigsby RM; Nephew KP
Gynecol Oncol; 2001 Aug; 82(2):299-304. PubMed ID: 11531283
[TBL] [Abstract][Full Text] [Related]
20. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.
Cho NY; Kim BH; Choi M; Yoo EJ; Moon KC; Cho YM; Kim D; Kang GH
J Pathol; 2007 Feb; 211(3):269-77. PubMed ID: 17139617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
